Form D · Other Health Care
KitoTech Medical, Inc.
Seattle, WA · CIK 0001611753
Offering snapshot reported Jun 28, 2024 · SEC filing
- Reported sold
- $200K Offering amount: $3M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 14, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 28, 2024 | Initial | $200,000 | No comparison | 2 | SEC filing |
| Dec 3, 2021 | Initial | $13,450,315 | No comparison | 153 | SEC filing |
| Nov 23, 2020 | Initial | $407,000 | No comparison | 4 | SEC filing |
| Aug 12, 2020 | Amendment | $2,262,470 | $1,962,470vs Jun 24, 2019 | 25 | SEC filing |
| Jun 24, 2019 | Initial | $300,000 | No comparison | 2 | SEC filing |
| Nov 2, 2018 | Amendment | $1,927,480 | $1,588,480vs Jan 2, 2018 | 69 | SEC filing |
| Jan 2, 2018 | Initial | $339,000 | No comparison | 9 | SEC filing |
| Mar 3, 2017 | Amendment | $494,993 | $444,993vs Mar 25, 2016 | 14 | SEC filing |
| Mar 25, 2016 | Initial | $50,000 | No comparison | 2 | SEC filing |
| Jan 8, 2015 | Initial | $1,651,479 | No comparison | 32 | SEC filing |
| Jul 11, 2014 | Initial | $100,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $330K (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-517278
A cash fee equal to 11% of gross proceeds received from investors identified by Paulson Investment Company,LLC. There is also a warrant to purchase a number of shares of common stock equal to 11% of the units sold in the offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Paulson Investment Company, LLC | 5670 |
Source: Form D, filed Jun 28, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald Berenson | Director, Executive |
| Ron Berenson | Director, Executive |
| John Brzezenski | Director |
| John Canady | Director |
| Imre Eszenyi | Director |
| Pat Fry | Director |
| Michael Gruber | Director |
| Henry Kim | Director |
| Cameron Pollock | Director |
| Jens Quistgaard | Director |
| Ed Truitt | Director |
| Edward Truitt | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
255 South King Street 8th Floor
Seattle, WA, 98104
Seattle, WA, 98104